Clinical trial
Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
NCT00005045 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00005045 |
|---|---|
| Title | Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer |
| Official title | Phase II Study of Carboxyamidotriazole (CAI, NSC #609974) in Patients With Advanced Renal Cell Carcinoma Refractory to Immunotherapy |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | carboxyamidotriazole |
| Start date | Mar 1, 2000 |
| Completion | Jun 1, 2004 |
| First posted | Jun 9, 2004 |
| Last update posted | Jun 21, 2013 |
| Countries | Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: